COVID-19 vaccines: where did we stand at the end of 2023?
K Lundstrom - Viruses, 2024 - mdpi.com
Vaccine development against SARS-CoV-2 has been highly successful in slowing down the
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …
Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study
Abstract Background Data on SARS-CoV-2 vaccine responsiveness in adolescent/young
adult (AYA) cancer patients are sparse. The present study assessed humoral and cellular …
adult (AYA) cancer patients are sparse. The present study assessed humoral and cellular …
Immunological Insights: A Multicenter Longitudinal Study on Humoral Response to COVID-19 Vaccines in Greece
E Makri, E Charvalos, E Stavropoulou… - Acta Microbiologica …, 2024 - mdpi.com
Vaccination has emerged as the most effective tool in the battle against COVID-19. To
optimize vaccination protocols, a deeper understanding of the immune response to …
optimize vaccination protocols, a deeper understanding of the immune response to …
COVID-19 Vaccines: Where Did We Stand at the End of 2023? Viruses 2024, 16, 203
K Lundstrom - 2024 - europepmc.org
Vaccine development against SARS-CoV-2 has been highly successful in slowing down the
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …
Niveles de IgG post vacunación SARS-CoV-2 Tipo ARN Vs. Vectores Víricos y vacunas inactivadas. Revisión Sistemática.
KC Morocho Salinas, JA Pérez Guaman - 2023 - dspace.ucacue.edu.ec
OBJECTIVE: To determine IgG levels post-SARS-CoV-2 vaccination with mRNA vaccines
compared to viral vectors and inactivated vaccines. MATERIALS AND METHODS: This …
compared to viral vectors and inactivated vaccines. MATERIALS AND METHODS: This …